CJ-15314

N/A

Report date: 2025/04/27 13:33:28
NME

Base Information

Drug NameCJ-15314
Drug Alias NameCJ-15314IN-115314IN-A002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionJanus kinase inhibitors
TargetsJanus kinase
Therapy Area/IndicationsAutoimmune DiseasesDermatitisDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesHK inno.N Corporation
China Registration ClassN/A

Develop Information

Active CompaniesHK inno.N Corporation
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesDermatitisDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A